Danny L. Dearen - Jan 18, 2022 Form 4 Insider Report for Axonics, Inc. (AXNX)

Role
Officer
Signature
/s/ Danny L. Dearen
Stock symbol
AXNX
Transactions as of
Jan 18, 2022
Transactions value $
-$851,010
Form type
4
Date filed
1/20/2022, 08:13 PM
Previous filing
May 24, 2021
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXNX Common Stock Options Exercise $153K +10.8K +108.05% $14.19* 20.8K Jan 18, 2022 Direct
transaction AXNX Common Stock Options Exercise $8.93K +5.48K +26.33% $1.63* 26.3K Jan 18, 2022 Direct
transaction AXNX Common Stock Options Exercise $5.28K +3.72K +14.15% $1.42* 30K Jan 18, 2022 Direct
transaction AXNX Common Stock Sale -$214K -4.31K -14.37% $49.73 25.7K Jan 18, 2022 Direct F1, F2
transaction AXNX Common Stock Sale -$496K -9.76K -37.98% $50.80 15.9K Jan 18, 2022 Direct F1, F3
transaction AXNX Common Stock Sale -$201K -3.89K -24.39% $51.68 12K Jan 18, 2022 Direct F1, F4
transaction AXNX Common Stock Sale -$108K -2.05K -16.98% $52.61 10K Jan 18, 2022 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXNX Stock Option (Right to Buy) Options Exercise $0 -10.8K -17.08% $0.00 52.5K Jan 18, 2022 Common Stock 10.8K $14.19 Direct F6
transaction AXNX Stock Option (Right to Buy) Options Exercise $0 -5.48K -18.94% $0.00 23.4K Jan 18, 2022 Common Stock 5.48K $1.63 Direct F7
transaction AXNX Stock Option (Right to Buy) Options Exercise $0 -3.72K -100% $0.00* 0 Jan 18, 2022 Common Stock 3.72K $1.42 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $49.35 to $50.305. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $50.40 to $51.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $51.425 to $52.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $52.46 to $53.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date.
F7 The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2018, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
F8 The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 21, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 21, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.